- Clear All
- Remove theAnesthesia & analgesiafilter Anesthesia & analgesia
- Remove theDermatologyfilter Dermatology
- Remove thePreventive medicinefilter Preventive medicine
- Remove theFelinefilter Feline
- Remove theEquinefilter Equine
- Remove theDrugs & vaccinesfilter Drugs & vaccines
- Remove thePersonal developmentfilter Personal development
JAVMA news
Pain points
The new Feline Grimace Scale is one of various tools that have been developed in recent years for pain assessment in cats and dogs. The key is…
JAVMA news
Board takes on topics across breadth of profession
The AVMA Board of Directors, while meeting June 20-21 in Washington, D.C., took on topics across the breadth of the profession, including improvement…
JAVMA news
To titer or to revaccinate
It remains confusing and even controversial whether antibody titers are a good measure of immunity when making decisions about
AVMA news
AAHA updates guidelines on pain management in dogs and cats
The new guidelines on pain management in dogs and cats from the American Animal Hospital Association include discussion of proactive and multimodal…
JAVMA news
Frustration mounts over opioid shortage
Drug shortages and discontinuations are nothing new to veterinary medicine.
AVMA news
AAHA publishes allergic skin disease guidelines for dogs, cats
On October 31, the American Animal Hospital Association (AAHA) announced the publication of the 2023 AAHA Management of Allergic Skin Diseases in Dogs…
JAVMA news
More itchy pets? No problem
More treatments available alongside increasing incidence or awareness of itchy dogs and cats
JAVMA news
1975 - 1985
In the decade that saw the glitter fade from disco, JAVMA carried articles that were of practical value—reports of new techniques and procedures, drug…
JAVMA news
It doesn’t have to hurt
The ethics of animal treatment and veterinary care have changed dramatically over the past several decades.
AVMA news
Generic drugs for treating inflammation, vomiting, parasites receive FDA approval
The Food and Drug Administration announced in March and April that it had approved six generic animal drugs.